Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04479241
Title A Phase 1 Study of PVSRIPO and Pembrolizumab in Patients With Recurrent Glioblastoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Istari Oncology, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California San Francisco San Francisco California 94143 United States Details
UConn Health Farmington Connecticut 06030 United States Details
Baptist MD Anderson Cancer Center Jacksonville Florida 32207 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 United States Details
The Ohio State University Columbus Ohio 43210 United States Details
Oregon Health and Science University Portland Oregon 97239 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field